Combining MRD with genetic knowledge in ALL

Measurable residual disease (MRD) is arguably the most useful single prognostic tool we have within the field of acute lymphoblastic leukemia (ALL), discusses Anthony Moorman, PhD, of Newcastle Univer... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts